Skip to content

TXG 10X GENOMICS INC

Follow

Stock (common), issuer CIK 1770787

Filings received so far for Q3 2026: 10 13F filers report a position in TXG shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Mirador Capital Partners LP33,979$3.07M0.36%-29,65713F-HRTimeline
Versant Capital Management, Inc18,185$1.64M0.14%-11,37413F-HRTimeline
Wedmont Private Capital9,254$715K0.02%-89013F-HRTimeline
Green Alpha Advisors, LLC5,890$532K0.36%-2,48213F-HRTimeline
GAMMA Investing LLC4,668$422K0.01%+37413F-HRTimeline
CoreCap Advisors, LLC1,752$158K<0.01%+1,70013F-HRTimeline
Farther Finance Advisors, LLC934$84.4K<0.01%+21513F-HRTimeline
ELEVATION WEALTH PARTNERS, LLC844$76.3K0.02%-64313F-HRTimeline
MassMutual Private Wealth & Trust, FSB484$43.7K<0.01%+7413F-HRTimeline
GoalVest Advisory LLC10$904<0.01%new13F-HRTimeline

Events

  • ARK Investment Management LLC and 1 other reporting person reported 6,272,998 TXG shares, 5.22% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0001104659-26-114392

    Accepted , ingested